According to Bloomberg News, Vinay Prasad, who oversees gene therapies at the FDA, said the plans will be published in early November. He foresees the approach sparking curiosity for the next wave of ...
CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, is a natural defense system in bacteria that scientists have adapted into a powerful gene-editing tool. This ...
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
This week's Senior Profile is on Owen Sinclair. He is the captain of the boys cross country team and indoor (winter) track ...
Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...
In this opinion piece, Lisa Nunez Safarian, incoming CEO of Inari, argues that consolidation in the seed business actively ...
Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...
Tiny viruses that only infect and kill bacteria can help treat deadly antibiotic-resistant bloodstream infections with ...
If gene-editing tomatoes proves effective, researchers hope to bring the first “sunshine tomato” to market within three years ...
Researchers at Washington University School of Medicine in St. Louis have identified central routes that two deadly viruses take to invade human cells and have designed decoy molecules that block the ...
Title: Cibus, Inc. Third Quarter 2025 Results Conference Call Event Date: Thursday, November 13, 2025 Time: 4:30 p.m. ET Participant Numbers: +1-800-274-8461 (U.S.), +1-203-518-9814 (International) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback